Imperial College London

DrJoachimMarti

Faculty of MedicineInstitute of Global Health Innovation

Honorary Senior Lecturer
 
 
 
//

Contact

 

+44 (0)20 3312 5630j.marti Website

 
 
//

Location

 

1021Queen Elizabeth the Queen Mother Wing (QEQM)St Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Marti:2016:10.1002/pon.3877,
author = {Marti, J and Hall, PS and Hamilton, P and Hulme, CT and Jones, H and Velikova, G and Ashley, L and Wright, P},
doi = {10.1002/pon.3877},
journal = {Psycho-Oncology},
pages = {77--83},
title = {The economic burden of cancer in the UK: a study of survivors treated with curative intent},
url = {http://dx.doi.org/10.1002/pon.3877},
volume = {25},
year = {2016}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - ObjectiveWe aim to describe the economic burden of UK cancer survivorship for breast, colorectal and prostate cancer patients treated with curative intent, 1 year post-diagnosis.MethodsPatient-level data were collected over a 3-month period 12–15 months post-diagnosis to estimate the monthly societal costs incurred by cancer survivors. Self-reported resource utilisation data were obtained via the electronic Patient-reported Outcomes from Cancer Survivors system and included community-based health and social care, medications, travel costs and informal care. Hospital costs were retrieved through data linkage. Multivariate regression analysis was used to examine cost predictors.ResultsOverall, 298 patients were included in the analysis, including 136 breast cancer, 83 colorectal cancer and 79 prostate cancer patients. The average monthly societal cost was $US409 (95%CI: $US316–$US502) [mean: £260, 95%CI: £198–£322] and was incurred by 92% of patients. This was divided into costs to the National Health Service (mean: $US279, 95%CI: $US207–$US351) [mean: £177, 95%CI: £131–£224], patients' out-of-pocket (OOP) expenses (mean: $US40, 95%CI: $US15–$US65) [mean: £25, 95%CI: £9–£42] and the cost of informal care (mean: $US110, 95%CI: $US57–$US162) [mean: £70, 95%CI: £38–£102]. The distribution of costs was skewed with a small number of patients incurring very high costs. Multivariate analyses showed higher societal costs for breast cancer patients. Significant predictors of OOP costs included age and socioeconomic deprivation.ConclusionsThis study found the economic burden of cancer survivorship is unevenly distributed in the population and that cancer survivors may still incur substantial costs over 1 year post-diagnosis. In addition, this study illustrates the feasibility of using an innovative online data collection platform to collect patient-repor
AU - Marti,J
AU - Hall,PS
AU - Hamilton,P
AU - Hulme,CT
AU - Jones,H
AU - Velikova,G
AU - Ashley,L
AU - Wright,P
DO - 10.1002/pon.3877
EP - 83
PY - 2016///
SN - 1057-9249
SP - 77
TI - The economic burden of cancer in the UK: a study of survivors treated with curative intent
T2 - Psycho-Oncology
UR - http://dx.doi.org/10.1002/pon.3877
VL - 25
ER -